The target audience for this ECHO series will be FQHC physicians, nurses, pharmacists, and care teams responsible for managing patients with diabetes and cardiometabolic diseases within the primary care and community health center context. It may also be of interest to other primary care providers and endocrinologists interested in providing diabetes care to special populations.

Upon completing this series, learners will be able to:

• Develop a practice of collaborative problem solving related to difficult diabetes cases, especially within vulnerable patient populations.
• Discuss best practices related to interdisciplinary care for FQHC patients with complex endocrine disease, including medical and behavioral health interventions.
• Analyze the impact of social determinants of health on endocrine disease and learn skills to engage complex patients in addressing health disparities.
• Evaluate tools for working with complex endocrine disease patients remotely.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

 

Nicolas Cuttriss, MD - Program Co-Chair AYUDA	Exploring the Relationship Between Diabetes and Cardiometabolic Disease	June 15, 2022
Christopher E. West, PhD, A-GNP-C Open Door Community Health Center	Managing Insulin-Requiring Diabetes in Vulnerable Populations	July 20, 2022
Jay Shubrook, DO Touro University California	Treatment Strategies for Vulnerable Populations with Diabetes Not Requiring Insulin	August 17, 2022
Kate Kirley, MD American Medical Association	Managing Pre-Diabetes	September 14, 2022
Elizabeth Beverly, PhD Ohio University	Diabetes, Depression, and Behavioral Health	October 12, 2022
Rayhan Lal, MD - Program Co-Chair Stanford University of Medicine	Role of Technology in Managing Diabetes in Rural Communities	November 16, 2022

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following faculty reported relevant financial relationships: Elizabeth Beverly, PhD - Journal of Osteopathic Medicine, Section Editor.  Nicolas Cuttriss, MD - ENDO Diabetes & Wellness, Employer; ECHO Diabetes Action Network, Employer; The Leona M. and Harry B. Helmsley Charitable Trust, Consultant; Cecelia Health; Consultant; American Youth Understanding Diabetes Abroad, Board. Kate Kirley, MD - American Medical Association, Employer. Rayhan Lal, MD - Abbott Diabetes Care, Consultant; Biolinq, Consultant; Capillary Biomedical, DSMB; Deep Valley Labs, Consultant; Gluroo, Consultant; Provention Bio, Advisory Board; Tidepool, Consultant. Jay Shubrook, DO - Abbott Diabetes Care, Consultant and Advisor; NovoNordisk, Consultant; Astra Zeneca, Advisor; Bayer, Advisor; Eli Lilly, Advisor; Nevro and Nevro, Advisor. 

The following faculty reported no relevant financial relationships: Christopher E. West, PhD, A-GNP-C 

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by an independent medical educational grant from Abbott Diabetes Care Inc.